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Abstract Background: It has been shown that abrupt re-exposure of ischemic myocardium to
oxygen can lead to increased peroxidative damage to myocytes (oxygen paradox). Controlled
cardiac reoxygenation, as an adjunct to substrate-enhanced cardioplegia, has been shown to
improve myocardial function and limit reperfusion injury when utilizing standardized hyper-
oxic cardiopulmonary bypass (CPB). The objective of our study was to evaluate the effect
of controlled reoxygenation on myocardial function following global ischemia employing
normoxic CPB.
Study design: Nineteen female swine (30e40 kg) were placed on vented, normoxic CPB. They
were subjected to 45e50 min of unprotected global ischemia (aortic cross clamping) followed
by 30 min of controlled cardiac reperfusion utilizing substrate-enhanced cardioplegia. Group 1
maintained normoxic pO2 (O2 tension of 90e110 mmHg). In Group 2, reoxygenation was titrated
gradually and increased from venous to arterial levels (O2 tensions from 40 to 110 mmHg over
15 min). Wemeasured coronary sinus blood samples for CK, CK-MB, nitric oxide, and conjugated
dienes at baseline, 5 min into the cardioplegic resuscitation, 5 min after the cross clamp
removal, and just prior to the termination of the study. Hearts were pathologically studied
and scored for evidence of tissue peroxidation.
Results: Although not significantly different, Group 1 (normoxic reperfusion) animals were
more likely to wean from CPB (p Z 0.141) and had a higher mean arterial pressure
(pZ 0.556). In Group 1, conjugated dienes were significantly higher 5 min into the resuscitative
protocol (pZ 0.018) and at the termination of bypass (pZ 0.035). Five of six animals in Group 1
eventually attained normal sinus rhythm as opposed to three out of 13 in Group 2 (pZ 0.041).
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154 J. Michael Smith et al.There was no significant difference in histology scoring between the two groups for tissue
peroxidation.
Conclusion: This study of controlled cardiac reoxygenation in a lethal ischemic swine model
failed to demonstrate that the use of controlled reoxygenation on the myocardial function
following global ischemia was better with maintained normoxic pO2 (with O2 tensions of
90e110 mmHg) than when reoxygenation was titrated gradually and increased from venous
to arterial levels (O2 tensions from 40 to 110 mmHg over 15 min).
ª 2006 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.Introduction
Reoxygenation injury occurs when hypoxic or ischemic
tissue is exposed to hyperoxic levels of molecular oxygen.1e4
This form of reperfusion injury, initially described by
Hearse et al.5 as the ‘‘oxygen paradox’’, appears to
result from the production of oxygen free radicals. Follow-
ing a period of hypoxia or ischemia, and upon reperfusion,
molecular oxygen undergoes sequential reduction to form
reactive species including superoxide anion (O2) and
hydroxyl radicals, as well as hydrogen peroxide.6 Previous
studies indicate these reactive oxygen species result in
reoxygenation injury through lipid oxidation (peroxidation)
of cell membranes via the classic HabereWeiss (Fenton)
pathway,7e9 or alternately by the interaction of nitric
oxide (NO) and O2 to form cytotoxic O2 species.10 Other
mechanisms, such as complement activation, can also
generate destructive oxygen species. The role of
reactive oxygen species in reperfusion injury is further
supported by studies showing antioxidant interventions
may block oxygen-mediated damage and improve cardiac
functional recovery.11
Clinically, reoxygenation injury has received the most
attention in congenital cyanotic heart surgery,12,13 and
in its role in reperfusion injury following adult cardiac
surgery7,14e16; both types of surgery, by convention, employ
cardiopulmonary bypass (CPB) circuits primed at oxygen
tensions (pO2) of 400 mmHg.
1 Recent studies, both in vitro
and in vivo, have documented the pO2 dependent relation-
ship to reoxygenation injury, and this can occur with the
institution of CPB prior to cross clamping.17 The concept
of controlled cardiac reoxygenation has emerged as
a strategy to ameliorate the damaging effects of abrupt
reexposure of molecular oxygen on hypoxic or ischemic
tissue.1,13,18,19
The purpose of our study was to determine the value of
controlled cardiac reoxygenation (while employing nor-
moxic CPB and utilizing substrate-enhanced cardioplegia)
on myocardial function following a lethal ischemic injury.19
Utilizing a resuscitative protocol, the value of controlling
for reoxygenation during the cardioplegic resuscitation
was compared between two groups of animals. Its effect
on cardiac function following a lethal injury and whether
it enabled better recovery in acutely injured ventricles
were measured utilizing the following parameters: (1)
return to normal sinus rhythm; (2) the ability of the animal
to wean from CPB; (3) maximal attainable blood pressure
after weaning from CPB; (4) the degree of myocyte damage
and peroxidative injury based on CK, CK-MB, nitric oxide
and conjugated diene levels; and (5) histological evidence
of tissue peroxidation injury to the myocardium.Methods
The protocol was approved by the Good Samaritan Hospital
Institutional Animal Care and Use Committee. Animal care
complied with the regulations of the Animal Welfare Act
9CFR of the Animal and Plant Health Inspection Service,
USDA. Nineteen 30e40 kg female swine were used for the
study.
Surgical procedures
The swine were pre-medicated with a mixture of Telazol,
Xylazine, and Ketamine intramuscularly and then anesthe-
tized and ventilated on a volume-limited respirator via an
endotracheal tube. FiO2 was titrated to keep a pO2 level of
90e110 mmHg. We performed a cutdown on the right groin
and cannulated the right femoral artery to monitor blood
pressure. After making a mid-line sternotomy incision, we
placed a sternal retractor then opened the pericardium
and sutured it to the lateral side wall to create a pericardial
well. Animals were heparinized for CPB with 3 mg of hepa-
rin per kilogram of body weight and placed on CPB through
the distal ascending aorta and the right atrial appendage
for venous return. Upon initiation of CPB, the aorta was im-
mediately cross clamped for 45e50 min and an apical left
ventricular vent was placed to decompress the heart. We
measured arterial blood gases, electrolytes, and hemoglo-
bin to ensure optimum extracorpeal circulation and used
a heating pad to keep the rectal temperature at 36 C. In
addition, pO2 was sampled from the systemic circulation
periodically during CPB to maintain pO2 > 100.
The CPB circuit consisted of a Cobe Optima Hollow Fiber
Oxygenator and hard shell open reservoir. Tubing size was
standardized at 3/8 inch diameter. The cardioplegia circuit
was a Cobe 4:1 ratio (blood:plegia). The bypass circuit was
primed with approximately 1500 ml of plasmalyte solution.
We used a roller pump to institute CPB and a Forane
vaporizer (on the pump) to maintain anesthesia. Aortic
pressures were kept at 50e60 mmHg by adjusting systemic
flow to approximately 100 ml/kg per min.
Experimental protocol
We maintained both groups on normoxic cardiopulmonary
bypass with pO2 oxygen tension between 90 and 110 mmHg.
In Group 1, the cardioplegia was delivered with normoxic
pO2. In Group 2, the cardioplegia was delivered with a con-
trolled reoxygenation protocol starting with a very low pO2
of 40 mmHg and titrating over 15 min to a normoxic level
of 120 mmHg (see diagram, Fig. 1). After 45e50 min of
Reoxygenation does not improve myocardial function 155unprotected global ischemia, we used substrate-enhanced
cardioplegic solution starting with 5 min of warm induction
and followed by intermittent cold cardioplegia and finally
a terminal hot shot. At this time, the cross clamp was
removed and after an additional 30 min of reperfusion,
the apical vent was removed and separation from bypass
was attempted. We terminated the study 30 min after the
first attempt to wean from bypass. No inotropes such as
dopamine or dobutamine were used during this study.
Induction of anesthesia 
Median sternotomy and initiation of CPB 
Coronary sinus blood samples (Time 1 = baseline) 
Unprotected cross-clamp for 45-50 minutes with apical venting 
Reperfusion cardioplegia with
normoxic pO2
Reperfusion cardioplegia with
superoxic pO2
Coronary sinus blood samples (Time 2 = 5 minutes into resuscitation) 
Release cross-clamp 
Coronary sinus blood samples (Time 3 = 5 minutes after cross clamp removal) 
Monitor and record cardiac rhythms
Need for defibrillation 
Attempt to wean from bypass
Maximum arterial pressure 
Cardiac tissue samples for pathology 
Coronary sinus blood samples (Time 4 = just prior to termination of study) 
Termination of study = 30 minutes after first attempt to wean from bypass 
Figure 1 Diagram of experimental procedure.Termination was whether or not the animal could be sepa-
rated from bypass, the status of their conduction system,
and whether or not they were able to sustain their own
blood pressure for 10 min.
Cardioplegia solutions were obtained from Central
Admixture Pharmacy Services, Inc. (C.A.P.S. Irvine, CA.).
The formulae for the substrate-enhanced cold induction,
warm induction, maintenance and reperfusion solutions are
shown in Table 1.
Blood samples were drawn from the coronary sinus at
baseline, 5 min into the cardioplegic resuscitation, 5 min
after the cross clamp removal, and just prior to the termi-
nation of the study. Cardiac tissue was excised and sent for
histological evaluation.
Laboratory analysis
The coronary sinus blood was centrifuged and the serum
was then divided into aliquots and frozen at 60 C until
laboratory assays were run.
Nitric oxide determination was by R&D Systems’ Total
Nitric Oxide Assay Kit.20 This ELISA assay is based on the
enzymatic conversion of nitrate to nitrite by the enzyme
nitrate reductase. The detection of total nitrite is then de-
termined as a colored azo-dye product of the Griess Reac-
tion that absorbs light at 540 nm.21 The microplates were
washed on a BioTec ELP 35 automated washer. Serum total
nitric oxide concentrations were determined by their opti-
cal density at 540 nm using a BioTec EL 312e microplate
reader and standards provided by R&D Systems.
Conjugated diene analysis was performed as follows:
0.5 ml of serum was extracted with 7 ml of a 2:1 chloro-
form:methanol (vol:vol) mixture. After vigorous mixing for
2 min and centrifugation (10 min at 1800 rpm), 5 ml of the
organic layer were dried under 95% N2 and 5% CO2 and
resuspended in 0.5 ml heptane. Optical density at 233 nm
was read versus a heptane blank with a Beckman DU 8
spectrophotometer.22,23
Creatinine kinase serum assays were performed using
the Beckman Synchron CX System. This methodology
utilizes creatine kinase to catalyze the transfer of a phos-
phate group from creatine phosphate to adenosine
diphosphate. The subsequent formation of adenosine tri-
phosphate was measured through the use of two coupled
reactions catalyzed by hexokinase and glucose-6-phosphate
dehydrogenase, which result in the production of reducedTable 1 Buckberg cardioplegia solutions
Ingredient Cold induction (ml) Warm induction (ml) Maintenance (ml) Reperfusion (ml)
Dextrose 50% in water 40 40
Dextrose 5% in water 220 200
Dex 5%/0.2% NaCl 550 550
CPD injection 50 225 50 225
Tromethamine 0.3 M,
sterile water for injection
200 225 200 225
Glutamate 5.35 g,
aspartate 4.90 g (0.46 M)
250 250
KCl (2 mEq/ml) 30 40 10 15
Total volume 830 1000 810 955
156 J. Michael Smith et al.B-nicotinamide adenine dinucleotide (NADH) from B-
nicotinamide (NAD). The system monitors the optical density
change of NAD to NADH at 340 nm.
Creatine kinase of muscle band serum assays were
performed using the Abbott AXSYM System. This system is
a Micropartical Enzyme Immunoassay (MEIA) utilizing the
principle of antibody-antigen complex formation.
Pathologic scoring
The pathologist was blinded to the protocol. Sections from
the left and right ventricles immediately adjacent to the
septum were evaluated for nuclear swelling, so-called wavy
fiber change, and perinuclear vacuolization. The last was
seen only in the subendocardial area, while the other two
occurred at various sites in the ventricular myocardium. All
of these changes are representative of sublethal ischemic
damage. Tissue was graded as a 1 for present and a 0 for
absent.
Outcome measurements
Outcomes measured included the cardiac rhythms after
removal of the cross clamp, whether the animals could be
separated from bypass, the maximum blood pressure
following bypass and the number of times defibrillation
was required.
Data analysis
Data were analyzed using SPSS statistical software (SPSS
Corporation, Chicago, Illinois). Continuous variables wereevaluated by Wilcoxon rank sum test. Categorical data
were analyzed by Fisher’s exact test. A p-value less than
0.05 was considered statistically significant.
Results
There were six animals in Group 1 and 13 in Group 2. In the
course of the study, after the first six animals had
undergone the experimental procedure for group 1, the
investigator felt that enough similar data had been col-
lected for group 1, and decided to concentrate remaining
resources on group 2.
Hemodynamics
Table 2 summarizes hemodynamic data from Group 1 and
Group 2. Five of the six Group 1 animals were successfully
separated from bypass even after the 50 min of ischemia
while five of 13 Group 2 animals were able to be separated
from bypass (pZ 0.141). Although not significantly differ-
ent, Group 1 had a higher median arterial pressure of
43 mmHg (range 31e75) after weaning from bypass
compared to Group 2 with a median of 33 mmHg (range
27e53) (pZ 0.556). Five of six animals in Group 1 eventu-
ally attained normal sinus rhythm as opposed to three of 13
in Group 2 (pZ 0.041).
Coronary sinus blood samples
Laboratory values for blood samples drawn at four specific
time periods are shown in Figs. 2e5. Conjugated dienes
differed significantly between Groups 1 and 2, 5 min intoTable 2 Hemodynamic data
Initial rhythm
after removal
of cross clamp
2nd rhythm 3rd rhythm Separation from
bypass achieved
Maximum postoperative
bypass blood pressure
Defibrillation
required?
Number
of times
defibrillated
Group 1
1 VFIB NSR Yes 33/6 Yes 5
2 VFIB ASYS NSR Yes 39/27 Yes 1
3 NSR Yes 33/24 Yes 2
4 VFIB NSR Yes 53/15 Yes 1
5 VFIB Yes 27/16 Yes 3
6 VFIb NSR No None Yes 8
Group 2
1 VFIB NSR Yes 34/15 Yes 2
2 None No None Yes 2
3 VFIB No None Yes 5
4 None No None Yes 1
5 None No None Yes 7
6 ASYS VFIB No None Yes 6
7 ASYS No None No
8 none Yes e Yes 1
9 VFIB Yes 52/28 Yes 2
10 VFIB No None Yes 1
11 NSR Yes 31/20 No
12 ASYS No None Yes 1
13 NSR Yes 75/36 Yes 6
VFIB, ventricular fibrillation; ASYS, asystole; NSR, normal sinus rhythm.
Reoxygenation does not improve myocardial function 157the resuscitative protocol (pZ 0.018) and at the termination
of bypass (pZ 0.035) (Table 3). All other laboratory values
were not significantly different between the two groups.
Pathologic scoring
Utilizing the above-mentioned scoring system, there was no
difference in tissue peroxidation between the two groups
(see Table 4).
Discussion
This study of controlled cardiac reoxygenation utilizing
normoxic bypass and normoxic cardioplegia solution calls
into question the beneficial effects of controlled cardiac
reoxygenation when employing normoxic conditions. Initi-
ating CPB with standardized hyperoxic solutions results in
a burst of oxygen free radicals that is associated with signs
of lipid peroxidation and is linked to enzyme released
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Figure 2 Nitric oxide measured at baseline (Time 1), 5 min
into the cardioplegic resuscitation (Time 2), 5 min after the
cross clamp removal (Time 3) and just prior to the termination
of the study (Time 4).
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Figure 3 Conjugated diene measured at baseline (Time 1),
5 min into the cardioplegic resuscitation (Time 2), 5 min after
the cross clamp removal (Time 3) and just prior to the termina-
tion of the study (Time 4).ultrastructural damage and functional depression.12,13,17,24
A precedent period of hypoxia depletes endogenous antiox-
idants, which become further exhausted with reoxygena-
tion.24 This has been linked in a doseeresponse way to
the oxygen tension in the CPB circuitry.1 In a similar fash-
ion, abrupt re-exposure of ischemic tissue to hyperoxic
flow also initiates significant reperfusion injury through
the reoxygenation pathyway.2e4,6,7,25 Normoxic bypass
limits this degree of injury. It has been suggested that initi-
ation of normoxic bypass with titration of the oxygen
tension to hyperoxic levels (pO2 400 mmHg) can still induce
reoxygenation injury no matter how gradually or abruptly
the change is made.26 However, it has been shown that con-
trolled cardiac reoxygenation up to hyperoxic levels can
prevent reoxygenation injury in the face of hyperoxic
CPB.18,27
In this study we specifically combined a normoxic pro-
tocol for CPB without titration to hyperoxic levels and
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Figure 4 Creatine kinase measured at baseline (Time 1),
5 min into the cardioplegic resuscitation (Time 2), 5 min after
the cross clamp removal (Time 3) and just prior to the termina-
tion of the study (Time 4).
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Figure 5 Creatine kinase of muscle band measured at base-
line (Time 1), 5 min into the cardioplegic resuscitation (Time 2),
5 min after the cross clamp removal (Time 3) and just prior to
the termination of the study (Time 4).
158 J. Michael Smith et al.Table 3 Descriptive Statistics for Serum Analyses
Test Time
point
Median Range p-value
NO (mmol/l) 1 85.0 27.0e302.0 0.661
2 59.0 17.0e233.0 1.000
3 64.0 22.0e266.0 0.930
4 59.0 22.0e280.0 0.895
CD (nm/0.5 ml) 1 0.9290 0.7300e1.3200 1.000
2 0.6930 0.5700e0.8800 0.188
3 0.7350 0.5800e0.9400 0.018*
4 0.8310 0.6100e1.1400 0.035*
CK (IU/l) 1 671.0 298.0e3952.0 0.483
2 776.0 217.0e2696.0 0.861
3 952.0 446.0e5732.0 0.726
4 1224.0 629.0e10,766.00 1.000
CK MB (ng/ml) 1 3.8 2.2e7.6 0.236
2 3.4 2.3e12.9 0.404
3 5.6 2.6e25.7 0.509
4 8.3 3.7e77.3 0.293
Time points: 1, baseline; 2, 5 min into cardioplegic resuscitation; 3, 5 min after cross clamp removal; and 4, just prior to the termination
of the study. NO, nitric oxide; CD, conjugated diene; CK, creatinine kinase; CK MB, creatinine kinase muscle band.tested whether there was any value for controlled cardiac
reoxygenation and limiting cardiac dysfunction in a swine
lethal ischemia injury model. We were unable to show any
significant advantage to controlled cardiac reoxygenation
over normoxic cardioplegia resuscitation utilizing sub-
strate-enhanced cardioplegia. It may be that there is little
benefit to further trying to limit oxygenation injury by
controlling the reoxygenation process with cardioplegia
under normoxic conditions. Prior studies have shown that
with hyperoxic CPB and hyperoxic cardioplegia in an
ischemic or hypoxic model, this protocol results in the
most significant reoxygenation injury.19
We attempted to quantify differences in the two groups
by measuring basic laboratory values for myocyte damage
of CK and CK-MB as well as evidence of oxygen radical
formation through the measurement of nitric oxide pro-
duction and specifically conjugated diene levels in the
coronary sinus blood. While there were statistically signif-
icantly lower levels of conjugated dienes produced in
Group 2, there were no differences in other blood levelsnor were there any differences in clinical outcomes.
Specifically, although the differences were not significantly
different Group 1 animals were more likely to return to
sinus rhythm and wean from bypass than those in Group 2.
Conduction tissue, which is especially sensitive to reperfu-
sion injury, was protected better in Group 1 as evidenced
by a higher likelihood of return to normal sinus rhythm than
Group 2.28,29 It has been shown that even normoxic bypass,
although attenuating the liberation of oxygen free radicals,
does not prevent this in a hypoxic or ischemic setting when
the FiO2 tension is further raised, either gradually or
abruptly, to hyperoxic levels. (1) It remains to be proven
whether or not there can be further benefit to cardiac
resuscitation by gradual reoxygenation to hyperoxic levels
while utilizing a normoxic CPB circuit. A major value to
titrating the oxygen tension both in the CPB circuit and car-
dioplegia (to limit reoxygenation injury both on CPB and in
myocardial resuscitation) is its clinical simplicity and appli-
cability to both congenital surgery as well as adult cardiac
surgery.Table 4 Pathologic scoring of anterior left and right ventricles
Evaluation Left ventricle Right ventricle
No. absent No. present p value for
Fisher’s exact test
No. absent No. present p value for
Fisher’s exact test
Nuclear swelling
Group 1 0 6 0.128 3 3 0.617
Group 2 5 8 9 4
Wavy fiber change
Group 1 2 4 1.000 5 1 0.333
Group 2 6 7 7 6
Perinuclear vacuolization
Group 1 2 4 0.350 6 0 1.000
Group 2 8 5 11 2
Reoxygenation does not improve myocardial function 159This study of controlled cardiac reoxygenation in a lethal
ischemic swine model failed to demonstrate that the use of
controlled reoxygenation on the myocardial function
following global ischemia was better with maintained
normoxic pO2 (with O2 tensions of 90e110 mmHg) than
when reoxygenation was titrated gradually and increased
from venous to arterial levels (O2 tensions from 40 to
110 mmHg over 15 min). This conclusion is based on out-
comes between the two groups as measured by return to
sinus rhythm, ability to wean from CPB, histological evalu-
ation of tissue for signs of peroxidation injury, and bio-
chemical analysis.
The subtle but real difference in conjugated dienes in the
controlled reoxgenation brings to question whether further
testing is warranted to detect more subtle degrees of
improved cardiac preservation with a controlled reoxy-
genation protocol in the face of normoxic bypass under
nonlethal injury patterns. Further investigation could include
comparing the effect of normoxic versus hyperoxic CPB in
a lethal ischemia model with and without controlled cardiac
reoxygenation as it relates to reperfusion injury. This may
corroborate our findings that normoxic CPB (as opposed to
hyperoxic CPB) is as beneficial and simple as controlled
cardiac reoxygenation in limiting reperfusion injury.
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